 CAMBRIDGE, Mass.--BUSINESS WIRE--Alnylam Pharmaceuticals, Inc. Nasdaq: ALNY, the leading RNAi therapeutics company, announced today that it plans to host its 9th annual series of RNAi Roundtable webinars over the coming weeks. The series will offer presentations from Alnylam scientists and program leaders who will review recent progress in a selection of the Companys pipeline programs and platform innovations, as well as medical thought leaders who will provide their perspectives on clin 